Skip to main content

Drug-discovery software company Schrödinger files for IPO

By MarketWatch  
   January 13, 2020

Schrödinger Inc. said it plans to launch an initial public offering, according to a Securities and Exchange Commission filing late Friday. Schrödinger said it plans to raise $100 million in the IPO, although that amount is usually used as a placeholder and is subject to revision in later filings.

Full story

Get the latest on healthcare leadership in your inbox.